A comparative study on the interaction of cis- and trans-platin with DNA and RNA

DNA and Cell Biology

Volumn 28, Issue 9, 2009, Pages 469-477

  Nafisi, Shohreh ^a   Norouzi, Zeinab ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BIOPOLYMER; CISPLATIN; CYTOSINE; DNA; DNA BASE; GUANINE; PHOSPHATE; PLATINUM DERIVATIVE; POLYNUCLEOTIDE; RNA; SODIUM CHLORIDE; THYMINE; TRANSPLATIN; URACIL;

ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; CELL DEATH; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); DRUG BINDING; DRUG STABILITY; FOURIER TRANSFORMATION; INFRARED RADIATION; ISOMER; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RNA BINDING; SPECTROSCOPY;

ANIMALS; BINDING SITES; CATTLE; CISPLATIN; DEOXYADENOSINES; DEOXYGUANOSINE; DNA; DNA ADDUCTS; KINETICS; NUCLEIC ACID CONFORMATION; RNA, FUNGAL; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STEREOISOMERISM; YEASTS;

EID: 69349085450     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.0894     Document Type: Article

References (56)

1. Ahmed Ouamer, A., Marty, R., Neault, J.F., and Tajmir-Riahi, H.A. (2004). AZT binds RNA at multiple sites. DNA Cell Biol 23, 783-788. (Pubitemid 39577754)
2. Ahmed Ouameur, A., and Tajmir-Riahi, H.A. (2004). Structural analysis of DNA interactions with biogenic polyamines and cobalt(III)hexamine studied by Fourier transform Infrared and capillary electrophoresis. J Biol Chem 279, 42041-42054.
3. Alex, S., and Dupuis, P. (1989). FT-IR and Raman investigation of cadmium binding by DNA. Inorg Chim Acta 157, 271-281.
4. 3+: VCD and AFM evidence of DNA condensation. Biopolymers 61, 243-260.
5. Arakawa, H., Ahmad, R., Naoui, M., and Tajmir-Riahi, H.A. (2000). A comparative study of calf thymus DNA binding to Cr(III) and Cr(VI) Ions. J Biol Chem 275, 10150-10153.
6. Bartz, S.R., Zhang, Z., Burchard, J., Imakura, M., Martin, M., Palmieri, A., Needham, R., Guo, J., Gordon, M., Chung, N., Warrener, P., Jackson, A.L., Carleton, M., Oatley, M., Locco, L., Santini, F., Smith, T., Kunapuli, P., Ferrer, M., Strulovici, B., Friend, S.H., and Linsley, P.S. (2006). Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol Cell Biol 26, 9377-9386. (Pubitemid 44904431)
7. Bosl, G.J., and Motzer, R.J. (1997). Testicular Germ-Cell. Cancer J Med 337, 242-253.
8. Brabec, V., and Leng, M. (1993). DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc Natl Acad Sci USA 90, 5345-5349. (Pubitemid 23183035)
9. Corey, D.R. (2007). Chemical Modification: the key to clinical application of RNA interference. J Clin Invest 117, 3615-3622.
10. Dean, J. (2003). Flavone: the molecular and mechanistic study of how a simple flavonoid protects DNA from oxidative damage [Ph.D. thesis]. East Tennessee State University, Johnson City, TN.
11. DiRico, D.E., Keller, P.B., and Hartmann, K.A. (1985). The infrared spectrum and structure of the type-I complex of silver and DNA. Nucl Acids Res 13, 251-260.
12. Eastman, A. (1987). The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther 34, 155-166.
13. Fichtinger-Shepman, A.M., Lohman, P.H., Berends, F., Reedjik, J., and Van Oosterom, A.T. (1986). Interactions of the antitumor drug cisplatin with DNA in vitro and in vivo, IARC. Sci Publ 78, 83-99.
14. Fichtinger-Schepman, A.M., van der Veer, J.L., Lohman, P.H., and Reedijk, J. (1985). Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 24, 707-713.
15. Giri, P., and Kumar, G.S. (2008). Self-Structure induction in single stranded poly(A) by small molecules: studies on DNA intercalators, partial intercalators and groove binding molecules. Mol Biosyst 4, 341-348.
16. Gralla, J.D., Sasse-Dwight, S., and Poljak, L.G. (1987). Formation of blocking lesions at identical DNA sequences by the nitrosourea and platinum classes of anticancer drugs. Cancer Res 47, 5092-5096. (Pubitemid 17146478)
17. Harder, H.C., Smith, R.G., and Leroy, A.F. (1976). Template primer inactivation by cis- and trans-dichlorodiammine platinum for human DNA polymerase alpha, beta, and Rauscher murine leukemia virus reverse transcriptase, as a mechanism of cytotoxicity. Cancer Res 36, 3821-3829.
18. Hayes, D., Cvitkovic, E., Golbey, R., Scheiner, E., and Krakoff, I.H. (1976). Amelioration of renal toxicity of high dose cis-platinum diammine dichloride (CPDD) by mannitol induced diuresis. Proc Am Assoc Cancer Res 17, 169-178.
19. Jamieson, E.R., and Lippard, S.J. (1999). Structure, recognition and processing of cis-platin-DNA adducts. Chem Rev 99, 2467-2498.
20. Kanakis, C.D., Nafisi, S., Rajabi, M., Shadaloi, A., and Tajmir-Riahi, H.A. (2009). Structural analysis of DNA and RNA interactions with antioxidant flavonoids. Spect Biomed Appl 23, 29-43.
21. Kanakis, C.D., Tarantilis, P.A., Polissiou, M.G., Diamantoglou, S., and Tajmir-Riahi, H.A. (2005). DNA interaction with naturally occurring antioxidant flavonoids quercetin, kaempferol and delphinidin. J Biomol Struct Dyn 22, 719-724. (Pubitemid 40696199)
22. Kanakis, C.D., Tarantilis, P.A., Polissiou, M.G., Diamatoglou, S., and Tajmir-Riahi, H.A. (2007). An overview of DNA and RNA to antioxidant flavonoids. Cell Biochem Biophys 49, 29-36.
23. Kelland, L.R., and Farrell, N.P. (2000). Platinum-Based Drugs in Cancer Therapy (Humana Press, Totowa, NJ), pp. 368-380.
24. Keller, P.B., and Hartman, K.A. (1986). The effect of ionic environment and mercury (II) on the alternative structures of DNA. An infrared spectroscopic study. Spectrochim Acta 42, 299-306.
25. Keys, H.M., Bundy, B.N., Stehman, F.B., Muderspach, L.I., Chafe, W.E., Suggs, C.L., Walker, J.L., and Gersell, D.N. (1999). Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340, 1154-1161.
26. Lambert, J.B., Shurvell, H.F., Lightner, D.A., and Cooks, R.G. (1998). Organic Structural Spectroscopy, chapters 10-11 (Prentice-Hall, Inc., Hillsdale, NJ).
27. 2+ ions on calf thymus DNA: binding sites and conformational changes. Biopolymers 30, 743-752.
28. 2] adduct of d(CCTCGATCTCC).d(GGAGACTCGAGG). Biochemistry 29, 811-823.
29. 2[d(ApGpGpCpCpT)-N7-A(1),N7-G(3)]]. Biochemistry 26, 5651-5657.
30. Lippard, S.J. (1987). Chemistry and molecular biology of platinum anticancer drugs. Pure Appl Chem 59, 731-742.
31. Loehrer, P.J., and Einhorn, L.H. (1984). Cisplatin. Ann Intern Med 100, 704-713.
32. Loprete, D.M., and Hartman, K.A. (1993). Conditions for the stability of the B, C and Z, structural forms of poly(dG-dC) in the presence of lithium, potassium, magnesium, calcium and zinc cations. Biochemistry 32, 4077-4082.
33. Marmur, J. (1961). A procedure for the isolation of deoxyribonucleic acid from microorganisms. J Mol Biol 3, 208-211.
34. Marty, R., N'soukpoé-Kossi, C.N., Charbonneau, D., Weinert, C.M., Kreplak, L., and Tajmir-Riahi, H.A. (2009). Structural analysis of DNA complexation with cationic lipids. Nucl Acids Res 37, 849-857.
35. Morris, M., Eifel, P.J., Lu, J., Grigsby, P.W., Levenback, C., Stevens, R.E., Rotman, M., Gershenson, D.M., and Mutch, D.G.N. (1999). Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer N Engl J Med 340, 1137-1143.
36. Nafisi, S., Adelzadeh, M., Norouzi, Z., and Sarbolouki, M.N. (2009). Curcumin binding to DNA and RNA. DNA Cell Biol 28, 201-208.
37. Nafisi, S., Hashemi, M., Rajabi, M., and Tajmir-Riahi, H.A. (2008). DNA adducts with antioxidant flavonoids: morin, apigenin and naringin. DNA Cell Biol 27, 433-442.
38. N'soukpoé-Kossi, C.N., Descôteaux, C., Asselin, É., Tajmir-Riahi, H.A., and Bérubé, G. (2008a). DNA interaction with novel antitumor estradiol-platinum (II) hybrid molecule: a comparative study with cis-platin drug. DNA Cell Biol 27, 101-107.
39. N'soukpoé-Kossi, C.N., Descôteaux, C., Asselin, É., Tajmir-Riahi, H.A., and Bérubé, G. (2008b). Transfer RNA bindings to antitumor estradiol-platinum(ii) hybrid and cisplatin. DNA Cell Biol 27, 1-7.
40. Pinto, A.P., and Lippard, S.J. (1985a). Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochem Biophys Acta 780, 167-180.
41. Pinto, A.P., and Lippard, S.J. (1985b) Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum(II). Proc Natl Acad Sci USA 82, 4616-4619. (Pubitemid 16239614)
42. Poluyanichko, A.M., Andrushchenko, V.V., Chikhirzhina, E.V., Vorob' Eb, V.I., and Wieser, H. (2004). The effect of manganese(II) on DNA structure: electronic and vibrational circular dichroism studies. Nucl Acids Res 32, 989-996.
43. Prescott, B., Steinmetz, W., and Thomas, G.J., Jr. (1984). Characterization of DNA structures by laser Raman spectroscopy. Biopolymers 23, 235-256.
44. Purtal, L.N., Bywater, M.J., Gu, W., Saunders, N.A., Gabrielli, B.G., Legatt, G.R., McMillan, N.A.J. (2005). RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cis-platin. Mol Pharmacol 68, 1311-1319. (Pubitemid 41539987)
45. Reedijk, J. (1987). The mechanism of action of platinum antitumor drugs. Pure Appl Chem 89, 181-192.
46. Rose, P.G., Bundy, B.N., Watkins, E.B., Thigpen, J.T., Deppe, G., Maiman, M.A., Clarke-Pearson, D.L., and Insalaco, S.N. (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340, 1144-1153. (Pubitemid 29177873)
47. Rosenberg, B., van Camp, L., and Krigas, T. (1965). Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205, 698-699.
48. Sherman, S.E., and Lippard, S.J. (1987). Structural aspects of platinum anticancer drug interactions with DNA. Chem Rev 87, 1153-1181.
49. Spiro, T.G. (1987). Biological Applications of Raman Spectroscopy ( John Wiley & Sons, NY), pp. 83-133.
50. Starikov, E.B., Semenov, M.A., Maleev, V.Y., and Gasan, I.A. (1991). Evidential study of correlated events in biochemistry: physicochemical mechanisms of nucleic acid hydration as revealed by factor analysis. Biopolymers 31, 255-261.
51. Stephanos, J.J. (1996). Drug-protein interactions: two-site binding of heterocyclic ligands to a monomeric hemoglobin. J Inorg Biochem 62, 155-169. (Pubitemid 126334783)
52. Taillandier, E., and Liquier, J. (1992). Infrared spectroscopy of DNA. Methods Enzymol 211, 307-335.
53. Tsuboi, M. (1969). Application of infrared spectroscopy to structure studies of nucleic acids. Appl Spectrosc Rev 3, 46-90.
54. Vijalakshmi, R., Kanthimathi, M., and Subramanian, V. (2000). DNA cleavage by a chromium(III) complex. Biochem Biophys Res Commun 271, 731-734.
55. Wang, G., Chuang, L., Zhang, Colton, S., Dombkowski, A., Renieres, J., Diakiv, A., and Xu, X.S. (2004). The initiativerole of XPC protein in cis-platin DNA damaging treatment mediated cell cycle regulation. Nucl Acids Res 32, 2231-2240. (Pubitemid 38854777)
56. Zhong, W., Wang, Y., Yu, J.-S., Liang, Y., Ni, K., and Tu, S. (2004). The interaction of human serum albumin with a novel antidiabetic agent - SU-118. J Pharm Sci 93, 1039-1046. (Pubitemid 38420413)